Fluconazole and Metronidazole Use in Pregnancy
Fluconazole in Pregnancy
Fluconazole should be avoided during the first trimester of pregnancy due to teratogenic risk, particularly cardiac malformations, and may be cautiously considered in the second and third trimesters only when the benefit clearly outweighs the risk. 1
First Trimester - Contraindicated
- Fluconazole exposure during the first trimester is associated with congenital malformations, including craniofacial ossification defects, thin wavy ribs, and renal pelvis defects 1
- Cardiac malformations are significantly increased, including cardiac septal defects (OR 1.3) and tetralogy of Fallot (OR 3.39) 2, 3
- Spontaneous abortion risk is nearly doubled (OR 1.99) with first-trimester fluconazole exposure 2, 4
- Even low-dose fluconazole (150 mg) is associated with increased heart defects (OR 1.95) 3
Second and Third Trimesters - Use with Extreme Caution
- The Infectious Diseases Society of America states that fluconazole use during the last 2 trimesters must be judged against the need for continuous antifungal exposure during pregnancy 1
- Fluconazole should only be used when amphotericin B is not appropriate and the maternal condition requires systemic antifungal therapy 1
- For limited and stable fungal infections, defer fluconazole treatment until after delivery with close monitoring during pregnancy 1
Dosing Considerations
- High-dose fluconazole (>150 mg or cumulative doses >600 mg) carries greater teratogenic risk (OR 1.19) compared to single low doses 2
- The FDA label warns that congenital malformations have been reported in infants whose mothers received fluconazole through or beyond the first trimester 5
Clinical Pitfall
- Do not confuse pregnancy safety with breastfeeding safety: fluconazole is considered safe during breastfeeding but NOT during pregnancy, particularly the first trimester 6
Metronidazole in Pregnancy
Metronidazole can be safely used throughout pregnancy, including the first trimester, as it is not associated with increased risk of congenital malformations or adverse pregnancy outcomes. 7, 8, 9
Safety Profile Across All Trimesters
- Multiple studies and meta-analyses have not demonstrated consistent associations between metronidazole use during pregnancy and teratogenic or mutagenic effects 7, 8
- The CDC confirms metronidazole is safe when clinically indicated and is not associated with increased risk of congenital malformations, premature births, stillbirths, spontaneous abortions, or low birth weight 8
- The FDA classifies metronidazole as Pregnancy Category B, meaning reproduction studies in rats at doses up to five times the human dose revealed no evidence of impaired fertility or harm to the fetus 9
Recommended Regimens in Pregnancy
For Bacterial Vaginosis:
- Metronidazole 250 mg orally three times daily for 7 days is the CDC-recommended regimen for pregnant women 7
- Alternative: Clindamycin 300 mg orally twice daily for 7 days 7
- All symptomatic pregnant women should be tested and treated for bacterial vaginosis to reduce adverse pregnancy outcomes 7
For Trichomoniasis:
- Metronidazole 2g orally as a single dose is the CDC-recommended treatment during pregnancy 8
- Treatment of sexual partners is essential to prevent reinfection 8
High-Risk Pregnant Women
- For high-risk pregnant women (history of preterm delivery), screening and treatment should occur in the early second trimester 7
- Systemic therapy is preferred over topical therapy during pregnancy to treat possible subclinical upper genital tract infections 7
Important Precautions
- Patients must avoid alcohol during metronidazole treatment and for 24 hours afterward due to potential disulfiram-like reactions 7, 8
- Metronidazole crosses the placental barrier and enters fetal circulation rapidly, but this does not translate to fetal harm 9
Clinical Context
- Bacterial vaginosis is associated with adverse pregnancy outcomes including preterm delivery, premature rupture of membranes, and preterm labor 7
- Treatment reduces the risk of these complications, making metronidazole use beneficial rather than harmful 7
Summary Algorithm
For vaginal candidiasis in pregnancy:
- First trimester: Use topical azole antifungals (miconazole, clotrimazole) - avoid oral fluconazole 1, 2, 3
- Second/third trimester: Topical azoles remain first-line; oral fluconazole only if topical therapy fails and benefit outweighs risk 1
For bacterial vaginosis or trichomoniasis in pregnancy: